Stryker Corporation (NYSE:SYK) updated its fourth quarter earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $1.92-1.97 for the period, compared to the Thomson Reuters consensus estimate of $1.93.
Several brokerages recently issued reports on SYK. Cowen and Company set a $166.00 price target on Stryker Corporation and gave the company a buy rating in a research note on Sunday, October 29th. Needham & Company LLC reissued a hold rating on shares of Stryker Corporation in a report on Friday, November 3rd. Oppenheimer Holdings, Inc. set a $156.00 target price on shares of Stryker Corporation and gave the stock a hold rating in a report on Monday, October 30th. Zacks Investment Research upgraded shares of Stryker Corporation from a sell rating to a hold rating in a research report on Tuesday, October 24th. Finally, Robert W. Baird reiterated a hold rating and set a $161.00 target price on shares of Stryker Corporation in a research report on Friday, October 27th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company. The stock presently has an average rating of Hold and a consensus target price of $151.52.
Shares of Stryker Corporation (SYK) opened at $154.48 on Friday. Stryker Corporation has a 1 year low of $106.48 and a 1 year high of $160.62. The stock has a market cap of $57,812.29, a P/E ratio of 24.48, a price-to-earnings-growth ratio of 2.43 and a beta of 0.79. The company has a current ratio of 2.37, a quick ratio of 1.61 and a debt-to-equity ratio of 0.63.
Stryker Corporation (NYSE:SYK) last released its earnings results on Thursday, October 26th. The medical technology company reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.50 by $0.02. Stryker Corporation had a net margin of 14.67% and a return on equity of 24.11%. The business had revenue of $3.01 billion for the quarter, compared to analyst estimates of $2.97 billion. During the same quarter in the previous year, the business earned $1.39 earnings per share. Stryker Corporation’s revenue for the quarter was up 6.1% on a year-over-year basis. sell-side analysts anticipate that Stryker Corporation will post 6.47 EPS for the current fiscal year.
In other Stryker Corporation news, insider Lonny J. Carpenter sold 5,000 shares of the stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $155.34, for a total transaction of $776,700.00. Following the completion of the sale, the insider now owns 83,207 shares of the company’s stock, valued at approximately $12,925,375.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 7.40% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Stryker Corporation (NYSE:SYK) Releases Q4 Earnings Guidance” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another publication, it was copied illegally and republished in violation of US & international trademark and copyright legislation. The original version of this story can be viewed at https://www.dispatchtribunal.com/2017/11/12/stryker-corporation-syk-issues-q4-earnings-guidance.html.
About Stryker Corporation
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.